- Home
- AKA vs XGN Comparison
AKA vs XGN Comparison
Compare AKA & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKA | XGN |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 110.7M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AKA | XGN |
|---|---|---|
| Price | $10.89 | $8.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $24.33 | $8.86 |
| AVG Volume (30 Days) | 2.0K | ★ 224.9K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | N/A |
| Revenue This Year | $6.14 | $8.12 |
| Revenue Next Year | $4.89 | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 4.44 | N/A |
| 52 Week Low | $8.42 | $2.59 |
| 52 Week High | $16.38 | $12.23 |
Technical Indicators
Market Signals| Indicator | AKA | XGN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 74.99 |
| Support Level | N/A | $4.08 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.36 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 0.00 | 94.63 |
Price Performance
Historical ComparisonAbout AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.